Fibrinogen Level as a Surrogate for the Outcome of Thrombolytic Therapy Using Tissue Plasminogen Activator for Acute Lower Extremity Intravascular Thrombosis
Conclusion:
Fibrinogen level ≤150 mg/dL is associated with increased risk of major bleeding during tPA infusions. We suggest serial fibrinogen measurement as a viable method to monitor bleeding risk during lower extremity tPA infusions.
Source: Vascular and Endovascular Surgery - Category: Surgery Authors: Skeik, N., Gits, C. C., Ehrenwald, E., Cragg, A. H. Tags: Clinical Research Articles Source Type: research